hourglass deformity. The success and feasibility of surgically correcting residual curvature after intralesional CCH remains poorly characterized.
METHODS: We performed a retrospective analysis of patients who had intralesional CCH treatment for Peyronie 0 s disease (PD) who subsequently underwent penile plication (PP), plaque incision and grafting (PIG), or inflatable penile prosthesis (IPP) placement as part of their treatment for residual curvature.
RESULTS: Nine men who underwent PP, PIG, or IPP for the treatment of residual curvature after intralesional CCH were identified (Table) . Six patients underwent PP, one patient underwent PIG and two patients underwent IPP with ancillary straightening maneuvers. The mean time (in days) from the last CCH injection to surgical correction was 128.9. The mean pre-CCH curvature was 69.4 degrees and the mean post-CCH curvature was 52.78 degrees. Seven out of nine patients had no residual curvature after surgical treatment. Increased fibrosis with increased surgical difficulty was noted in three out of nine patients. No post-operative complications were noted.
CONCLUSIONS: The surgical treatment of PD after intralesional CCH is safe and effective in men who desire correction of residual curvature. There may be increased technical difficulty in some patients.
Source of Funding: None

PD31-09 PENILE PROSTHESIS IMPLANTATION (PPI) PLUS CORPOREAL RECONSTRUCTION WITH COLLAGEN-FLEECE GRAFTING IN THE TREATMENT OF PEYRONIE'S DISEASE (PD) WITH OR WITHOUT ED
INTRODUCTION AND OBJECTIVES:
The most successful treatment option of Peyronie's disease remains surgical, despite also being the most invasive. There are described several techniques for the correction of penile curvature, being technically demanding those in which grafts are used. We present our initial experience and preliminary results of partial plaque incision and grafting with self-adhesive film containing collagen combined with PPI (inflatable or malleable) in the treatment of Peyronie's disease.
METHODS: Between January 2015 and August 2016 we operated 14 patients using this technique, six by implantation of a malleable prosthesis and the other eight with inflatable. Five of them kept proper erectile function and three had significant shortening of the penis without curvature. Four of them had been previously operated: one inflatable prosthesis + modeling; and other with sequelae after simple plication. The mean presurgical PDQ PD bother score was 9.7(8-12). Surgery was performed in the case of malleable through a single incision (with penile degloving) while IPP was performed either by 2 incisions (scrotal + penile degloving) or through a single incision (Kulkarni approach). Curvature correction was made by partial plaque incision with an H modified technique in the area of maximum curvature (or corporeal relaxing incisions) and placing a patch without suturing, covering prosthethic material.
RESULTS: The mean operative time was 69 (55-85) min. The mean postsurgical penile lengthening was 4.5 (3-6) cm. There was an improvement in PDQ PD bother score of 4.5(2-5) points. No patients had hematoma, glans isquemia or any infectious complications. All patients showed good capability of penetration and correction of the penile curvature (<10 grades of residual curvature in the seven patients) 3 months after surgery. Six patients had glans hypoestesia at this time, while after the first three months, only 3 of them remains symptomatic. The overall satisfaction rate was of 90%.
CONCLUSIONS: In our experience, plaque incision and collagen fleece grafting during penile prosthesis implantation seems to be a safe and reproducible technique that yelds higher satisfaction rates and greater penile lengthening than prosthesis implantation alone. Also this technique could be consider in the management of sequalae after PD surgery. METHODS: Tissue specimens were collected from PD patients after surgery with patients 0 consent and institutional approval and stored frozen. X-rays were used to identify postsurgical specimens with mineralization. The soft tissues in PD plaques with mineral foci were digested with 0.2% pronase for 2h followed by 0.025% bacterial collagenase P overnight at 37 o C. Mineral foci resistant to enzyme digestion were gold coated and analysed by EDS using a JEOL JSM electron microscope. Other PD plaques were fixed with ethanol and phosphotungstic acid (PTA) and imaged by micro CT.
RESULTS: Mineral foci in PD plaques were resistant to enzyme digestions by the general protease pronase and subsequent digestion by bacterial collagenase. When the mineral content of the enzyme resistant foci were analysed by EDS they showed a Ca/P ratio of 1.80 +/-0.09. The Ca/P ratios were very similar for both large and small foci. For comparison rabbit tibial bone treated in a similar manner had Ca/P ratio of 1.76 +/-0.09. The location of the mineral within the collagenous plaques was imaged using micro CT with PTA as a contrast agent to stain the collagen fibers. Micro CT images of the mineralized plaques showed mineral deposition at the interface between collagenous layers with different degrees of PTA stain contrast.
CONCLUSIONS: Mineral foci in PD plaques were enzyme resistant. The high Ca/P ratio (1.80) of mineral deposits in PD plaques were indicative of mature hydroxyapatite (Ca/P 1.67) found in bone. This high ratio was similar in both small and large mineral foci in the PD enzyme resistant tissues. The location of the mineral deposits and adjacent unmineralized collagenous matrix could readily be visualized by micro CT when PTA was used to stain the collagen fibers. INTRODUCTION AND OBJECTIVES: Calcified Peyronie's plaque (CPP) is thought to be mineralized type I collagen of the tunica albuginea (TA) and within the corpus cavernosum (CC). The mechanistic link transforming a fibrous and vascularized to a mineralized tissue and subsequently impairing function at an organ-level is poorly understood. It is hypothesized that origins of CPP lay at the interface between the circumferential TA and CC, in that the residing pericytes around small diameter vessels produce osteogenic markers, prompting calcification at the CC-TA interface.
METHODS: Twelve human CPPs were surgically excised, fixed, dehydrated and scanned using a high resolution X-ray computed tomography (micro-CT) at 4X and 10X magnifications (4.5mm and 1.8mm voxel size respectively) and further analyzed with AVIZO for mineral density, porosity and structure. Tissues were processed and stained histologically, and imaged using an Olympus BX51 microscope.
RESULTS: CPP contained pores (A) with a diameter range of 10-18mm (A, C), see figure. Micro-CT data demonstrated an interface with a lower mineral density of 765 AE172mg/cc between layers 1 and 2 (A in figure) compared to the average mineral density of 1049 AE142mg/ cc. Interfacial zone between TA and CC contained tubules of diameter 18AE3.5mm with mineralized lumen walls (A). Histological analyses of seemingly non-calcified regions adjacent to CPP, contained similar diameter tubules patent with erythrocytes (region 1 in B in figure) , and were within a disorganized extracellular matrix (ECM) positive for increased expression of elastin (bottom row, elastin) within regions positive for alizarin red (bottom row, AR: mineral). These patterns were consistently observed at the interface between TA and CC regions.
CONCLUSIONS: The branch-like structure of 10-18mm pores is similar to that of the venous structure at the interface between the TA and CC, suggesting that cells within and around the small diameter vessel could play a role in biomineralization, likely following an insult on the outer layers of the TA. Increased expression of elastin alters ECM stiffness within the outer TA prompting a change in smooth muscle stiffness of the CC, and collectively over time can receive signals from the interface to accelerate biomineralization along the length of the penis. Peyronie 0 s disease (PD) is inherited in a subset of men and has a co-prevalence of z20% in men with Dupuytren 0 s disease (DD), a related fibrotic diathesis. Recent forward-genetic screening for genetic factors with potential involvement in PD and DD identified several candidate genes involved in fibrosis and inflammation. Here, we examine nucleotide-level genetic alterations with potential involvement in pathogenesis of PD and DD in a father-son duo using whole-exome sequencing.
METHODS: Whole-exome genomic data was generated at the RNA and Genomic Profiling Sequencing Core (https://www.bcm.edu/ garp/), and mapped using BOWTIE2 to the human genome build UCSC hg19; single nucleotide variants (SNVs) were inferred using the GATK platform and annotated using the annovar software, and then filtered for novel, non-synonymous SNVs. Enriched pathways were determined using the Gene Set Enrichment (GSEA) method, and the gene set collection from the Molecular Signature Database (MSigDB).
RESULTS: Whole-exome sequencing identified 95/117 unique SNVs in each sample, with 150 SNVs shared between the two samples. Further analysis identified 150 nonsynonymous SNVs shared between the samples. Pathway analysis revealed enrichment of genes in known PD and DD pathogenic pathways including collagen formation / extracellular matrix organization (COL1A2, CRTAP), regulation of cell proliferation (SPEG, QSOX1, FGR1OP, LRP5), and the inflammatory response (HLA-DRB5, KDM6B). Several pathways not previously implicated in PD and DD were identified, including chromosomal rearrangement (FGFR1OP, COL1A2, AUTS2, AFF1, SHANK3), EGF-like domain-containing genes (MUC3A, SNED1, CD93, FAT2, SSPO, LRP5, MUC4), and maintenance of gastrointestinal epithelium (MUC2, MUC6, MUC4). SNVs in disease-associated genes, including osteoporosis and Parkinson 0 s disease, as well as SNVs in genes involved in head and neck, genitourinary, gastrointestinal, neurologic, and lung malignancies, were also identified. Neither of the two family members have reported any of the listed conditions to date.
CONCLUSIONS: In addition to pathways that can affect fibrosis, men with a genetic predisposition to PD and DD exhibit genetic alterations in cellular functions and disease-related pathways, including malignancies. This is the first study to genetically link fibrotic diatheses to other health conditions, and future work should focus on confirming these relationships. Moreover, men with PD or DD may warrant additional follow-up after diagnosis and treatment of these conditions.
